Notably, most drugs improved NAFLD by acting on hepatic CYP7A1, indicating that the BA synthesis pathway accounts for a large proportion of treatment with plant herbs. The gene discussed is CYP7A1; the disease is metabolic dysfunction-associated steatotic liver disease.